Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Drylet is a private environmental biotechnology company that develops commercial bioremediation products for wastewater, sludge, manure, grease, and anaerobic digestion systems. Rather than operating as a therapeutic biotech or pharma developer, the company uses a patented microbe-delivery platform that combines material science and microbiology to deliver selected non-GMO microbes into organic waste streams. Its products are marketed to municipal wastewater, livestock, food service, renewable energy, and protein processing customers to reduce solids and odors, improve lagoon and wastewater performance, and increase biogas generation. Drylet also offers sonar mapping and technical assessment services to support waste-treatment optimization. The company appears to be an active, venture-backed private company headquartered in Houston, Texas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Drylet.